4DMedical Ltd Wins EU CE Mark, Raises A$83 Million as Mayo Clinic Deal Boosts CT:VQ Push
4DMedical said Friday its CT:VQ lung imaging software won CE mark clearance in the EU and secured A$83 million in a private placement at A$5.90 a share. The company expects to have A$289 million in cash at year-end 2025. Mayo Clinic began using CT:VQ on March 25, joining five other U.S. academic centers since FDA clearance in September. Shares closed at A$6.28 after touching A$7.55 intraday.